IL13 and allergic disease: By recruiting Th2 cells at the site of inflammation, CCL17 and CCL22 promote further proinflammatory activities by the Th2 secretion of allergy-promoting cytokines like interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-13 (IL-13) responsible for the promotion of immunoglobulin E (IgE) production by B cells [14].